본문 바로가기
KERD
논문KCI 등재

Weight Loss as a Nonpharmacologic Strategy for Erosive Esophagitis: A 5-Year Follow-up Study

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Background/Aims: Obesity is a risk factor for gastroesophageal reflux disease (GERD), with several studies demonstrating positive associations between body mass index (BMI) and GERD symptoms. However, little is known about the effect of BMI changes on erosive esophagitis (EE). In this study, we investigated whether BMI reduction could resolve EE. Methods: A retrospective cohort study was performed to assess the natural course of EE according to changes in BMI. Participants undergoing health check-ups from 2006 to 2012 were enrolled, and 1,126 subjects with EE were included. The degree of esophagitis was measured by upper endoscopy and serially checked over a 5-year follow-up. Logistic regression and Cox proportional hazards models were used to investigate the association between BMI reduction and EE resolution. Results: Substantial weight loss is associated with EE resolution. The adjusted odds ratio for EE resolution was 1.44 (95% confidence interval [CI], 1.09 to 1.92) among participants with a decrease in BMI compared to those with no decrease in BMI. The EE resolution rate was related to the degree of BMI reduction. The effect of weight loss on EE resolution was higher among subjects who lost more weight. Compared with subjects with no decrease in BMI, the hazard ratios for EE resolution were 1.09 (95% CI, 0.89 to 1.35), 1.31 (95% CI, 1.01 to 1.72) and 2.12 (95% CI, 1.44 to 3.12) in subjects with BMI reductions of ≤1, 1–2, and >2 kg/m2, respectively. Conclusions: EE resolution is associated with a decrease in BMI, and weight loss is potentially an effective GERD treatment.

Abstract

Background/Aims: Obesity is a risk factor for gastroesophageal reflux disease (GERD), with several studies demonstrating positive associations between body mass index (BMI) and GERD symptoms. However, little is known about the effect of BMI changes on erosive esophagitis (EE). In this study, we investigated whether BMI reduction could resolve EE. Methods: A retrospective cohort study was performed to assess the natural course of EE according to changes in BMI. Participants undergoing health check-ups from 2006 to 2012 were enrolled, and 1,126 subjects with EE were included. The degree of esophagitis was measured by upper endoscopy and serially checked over a 5-year follow-up. Logistic regression and Cox proportional hazards models were used to investigate the association between BMI reduction and EE resolution. Results: Substantial weight loss is associated with EE resolution. The adjusted odds ratio for EE resolution was 1.44 (95% confidence interval [CI], 1.09 to 1.92) among participants with a decrease in BMI compared to those with no decrease in BMI. The EE resolution rate was related to the degree of BMI reduction. The effect of weight loss on EE resolution was higher among subjects who lost more weight. Compared with subjects with no decrease in BMI, the hazard ratios for EE resolution were 1.09 (95% CI, 0.89 to 1.35), 1.31 (95% CI, 1.01 to 1.72) and 2.12 (95% CI, 1.44 to 3.12) in subjects with BMI reductions of ≤1, 1–2, and >2 kg/m2, respectively. Conclusions: EE resolution is associated with a decrease in BMI, and weight loss is potentially an effective GERD treatment.

참고문헌 (38)

  1. Francis DO, "High economic burden of caring for patients with suspected extraesophageal reflux", Am J Gastroenterol, 108, pp.905~911 (2013)
  2. Shaheen N, "Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review", JAMA, 287, pp.1972~1981 (2002)
  3. Sharma P, "Racial and geographic issues in gastroesophageal reflux disease", Am J Gastroenterol, 103, pp.2669~2680 (2008)
  4. Goh KL, "Gastroesophageal reflux disease in Asia: a historical perspective and present challenges", J Gastroenterol Hepatol, 26(Suppl 1), pp.2~10 (2011)
  5. El-Serag HB, "Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review", Gut, 63, pp.871~880 (2014)
  6. 정혜경, "Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review", Journal of Neurogastroenterology and Motility (JNM), 17(1), pp.14~27 (2011), 대한소화기 기능성질환∙운동학회
  7. Ronkainen J, "Epidemiology of reflux symptoms and GORD", Best Pract Res Clin Gastroenterol, 27, pp.325~337 (2013)
  8. Kang JH, "Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations", Ther Adv Chronic Dis, 6, pp.51~64 (2015)
  9. Kahrilas PJ, "American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease", Gastroenterology, 135, pp.1383~1391 (2008)
  10. Harvey RF, "Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis", Lancet, 2, pp.1200~1203 (1987)
  11. Ness-Jensen E, "Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study", Am J Gastroenterol, 109, pp.171~177 (2014)
  12. Corley DA, "Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis", Am J Gastroenterol, 101, pp.2619~2628 (2006)
  13. Eslick GD, "Gastrointestinal symptoms and obesity: a meta-analysis", Obes Rev, 13, pp.469~479 (2012)
  14. Jacobson BC, "Body-mass index and symptoms of gastroesophageal reflux in women", N Engl J Med, 354, pp.2340~2348 (2006)
  15. Hampel H, "Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications", Ann Intern Med, 143, pp.199~211 (2005)
  16. El-Serag HB, "Obesity is an independent risk factor for GERD symptoms and erosive esophagitis", Am J Gastroenterol, 100, pp.1243~1250 (2005)
  17. Kang MS, "Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population", J Gastroenterol Hepatol, 22, pp.1656~1661 (2007)
  18. Lee HL, "Association between GERD-related erosive esophagitis and obesity", J Clin Gastroenterol, 42, pp.672~675 (2008)
  19. Cai N, "Association between body mass index and erosive esophagitis: a meta-analysis", World J Gastroenterol, 18, pp.2545~2553 (2012)
  20. Peery AF, "Burden of gastrointestinal disease in the United States: 2012 update", Gastroenterology, 143, pp.1179~1187 (2012)
  21. Vaezi MF, "Complications of proton pump inhibitor therapy", Gastroenterology, 153, pp.35~48 (2017)
  22. Alberti KG, "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
  23. Hamaguchi M, "The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation", Am J Gastroenterol, 102, pp.2708~2715 (2007)
  24. Armstrong D, "The endoscopic assessment of esophagitis: a progress report on observer agreement", Gastroenterology, 111, pp.85~92 (1996)
  25. Park JH, "Metabolic syndrome is associated with erosive esophagitis", World J Gastroenterol, 14, pp.5442~5447 (2008)
  26. Pandolfino JE, "Obesity: a challenge to esophagogastric junction integrity", Gastroenterology, 130, pp.639~649 (2006)
  27. El-Serag HB, "Anthropometric correlates of intragastric pressure", Scand J Gastroenterol, 41, pp.887~891 (2006)
  28. 정희선, "Obesity Is Associated With Increasing Esophageal Acid Exposure in Korean Patients With Gastroesophageal Reflux Disease Symptoms", Journal of Neurogastroenterology and Motility (JNM), 19(3), pp.338~343 (2013), 대한소화기 기능성질환∙운동학회
  29. Kouklakis G, "Relationship between obesity and gastroesophageal reflux disease as recorded by 3-hour esophageal pH monitoring", Rom J Gastroenterol, 14, pp.117~121 (2005)
  30. Wu JC, "Obesity is associated with increased transient lower esophageal sphincter relaxation", Gastroenterology, 132, pp.883~889 (2007)
  31. Tilg H, "Visceral adipose tissue attacks beyond the liver: esophagogastric junction as a new target", Gastroenterology, 139, pp.1823~1826 (2010)
  32. Kjellin A, "Gastroesophageal reflux in obese patients is not reduced by weight reduction", Scand J Gastroenterol, 31, pp.1047~1051 (1996)
  33. Cremonini F, "Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort", Neurogastroenterol Motil, 18, pp.987~994 (2006)
  34. Ness-Jensen E, "Weight loss and reduction in gastroesophageal reflux. A prospective population- based cohort study: the HUNT study", Am J Gastroenterol, 108, pp.376~382 (2013)
  35. Singh M, "Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial", Obesity (Silver Spring), 21, pp.284~290 (2013)
  36. Park SK, "Weight loss and waist reduction is associated with improvement in gastroesophageal disease reflux symptoms: a longitudinal study of 15 295 subjects undergoing health checkups", Neurogastroenterol Motil, 29, pp.e13009~ (2017)
  37. Labenz J, "Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease", Am J Gastroenterol, 101, pp.2457~2462 (2006)
  38. Vakil N, "The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus", Am J Gastroenterol, 101, pp.1900~1920 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (17건)